Navani V, Heng DYC. Immunotherapy in renal cell carcinoma.
Lancet Oncol 2023;
24:1164-1166. [PMID:
37844599 DOI:
10.1016/s1470-2045(23)00473-4]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2023] [Accepted: 09/19/2023] [Indexed: 10/18/2023]